UTHR vs ROKU
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
UTHR · United Therapeutics$562.02 ▼ 0.65%
ROKU · Roku Inc$160.52 ▲ 0.09%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- UTHR +23.8%
- ROKU +52.9%
Head to head
| Metric | UTHR | ROKU |
|---|---|---|
| Price | $562.02 | $160.52 |
| Change today | ▼ 0.65% | ▲ 0.09% |
| Market cap | $23.94B | $23.93B |
| Return, 3 months | +6.1% | +5.7% |
| Return, year to date | +15.3% | +48.0% |
| Return, 1 year | +25.2% | +56.9% |
| P/E (TTM) | 21.2 | 47.4 |
| P/B | 3.8 | 7.9 |
| P/E percentile vs own 5y | 98th | 71st |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +4.1% | +21.9% |
| Net profit growth (YoY) | -23.6% | +1,463.5% |
| Gross margin | 86.3% | 45.5% |
| Operating margin | 39.4% | 5.2% |
| Net margin | 38.6% | 6.8% |
| Return on equity | 19.1% | 13.1% |
| Analyst target vs. price | +21.8% | -0.3% |
| Analyst buy share | 77% | 0% |
| RSI (14) | 49 | 61 |
| 30-day volatility | 50.8% | 15.0% |
| Max drawdown, 1 year | -20.9% | -27.7% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- UTHR is the largest of the group by market value.
- ROKU has returned the most over the past year.
- UTHR carries the lowest trailing P/E.
- ROKU is growing revenue fastest.
- UTHR keeps the most profit per dollar of sales.
- ROKU has been the calmest stock over the last 30 days.